Weybosset Research & Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-8,397
| Closed | -$343K | – | 54 |
|
|
2023
Q1 | $343K | Hold |
8,397
| – | – | 0.13% | 37 |
|
|
2022
Q4 | $430K | Hold |
8,397
| – | – | 0.17% | 32 |
|
|
2022
Q3 | $367K | Buy |
8,397
+500
| +6% | +$24.3K | 0.16% | 33 |
|
|
2022
Q2 | $414K | Buy |
+7,897
| New | +$402K | 0.2% | 27 |
|
|
2021
Q4 | $543K | Hold |
9,197
| – | – | 0.2% | 29 |
|
|
2021
Q3 | $396K | Hold |
9,197
| – | – | 0.16% | 33 |
|
|
2021
Q2 | $360K | Hold |
9,197
| – | – | 0.15% | 39 |
|
|
2021
Q1 | $333K | Sell |
9,197
-50
| -0.5% | -$1.77K | 0.14% | 43 |
|
|
2020
Q4 | $340K | Sell |
9,247
-1,553
| -14% | -$57K | 0.16% | 35 |
|
|
2020
Q3 | $376K | Buy |
+10,800
| New | +$379K | 0.21% | 34 |
|
|
2020
Q2 | – | Sell |
-13,593
| Closed | -$410K | – | 54 |
|
|
2020
Q1 | $410K | Hold |
13,593
| – | – | 0.29% | 31 |
|
|
2019
Q4 | $505K | Buy |
13,593
+52
| +0.4% | +$1.85K | 0.26% | 35 |
|
|
2019
Q3 | $462K | Hold |
13,541
| – | – | 0.26% | 37 |
|
|
2019
Q2 | $557K | Buy |
13,541
+264
| +2% | +$10.5K | 0.32% | 30 |
|
|
2019
Q1 | $535K | Buy |
13,277
+105
| +0.8% | +$4.21K | 0.31% | 31 |
|
|
2018
Q4 | $545K | Sell |
13,172
-316
| -2% | -$13.1K | 0.37% | 28 |
|
|
2018
Q3 | $564K | Hold |
13,488
| – | – | 0.33% | 31 |
|
|
2018
Q2 | $464K | Sell |
13,488
-53
| -0.4% | -$1.81K | 0.28% | 34 |
|
|
2018
Q1 | $456K | Hold |
13,541
| – | – | 0.27% | 34 |
|
|
2017
Q4 | $465K | Buy |
13,541
+1,581
| +13% | +$53.9K | 0.28% | 39 |
|
|
2017
Q3 | $405K | Hold |
11,960
| – | – | 0.27% | 39 |
|
|
2017
Q2 | $381K | Hold |
11,960
| – | – | 0.25% | 40 |
|
|
2017
Q1 | $388K | Hold |
11,960
| – | – | 0.26% | 39 |
|
|
2016
Q4 | $369K | Buy |
11,960
+422
| +4% | +$12.9K | 0.26% | 41 |
|
|
2016
Q3 | $371K | Hold |
11,538
| – | – | 0.27% | 41 |
|
|
2016
Q2 | $385K | Hold |
11,538
| – | – | 0.29% | 40 |
|
|
2016
Q1 | $324K | Buy |
11,538
+3,162
| +38% | +$90.3K | 0.27% | 40 |
|
|
2015
Q4 | $257K | Sell |
8,376
-53
| -0.6% | -$1.67K | 0.23% | 45 |
|
|
2015
Q3 | $251K | Hold |
8,429
| – | – | 0.19% | 46 |
|
|
2015
Q2 | $268K | Hold |
8,429
| – | – | 0.18% | 46 |
|
|
2015
Q1 | $278K | Buy |
8,429
+264
| +3% | +$8.39K | 0.18% | 45 |
|
|
2014
Q4 | $241K | Hold |
8,165
| – | – | 0.15% | 48 |
|
|
2014
Q3 | $229K | Hold |
8,165
| – | – | 0.15% | 48 |
|
|
2014
Q2 | $230K | Buy |
8,165
+1,396
| +21% | +$39.8K | 0.15% | 49 |
|
|
2014
Q1 | $206K | Buy |
+6,769
| New | +$202K | 0.14% | 49 |
|
Other funds holding PFE
Weybosset Research & Management's PFE Position: Q2 2023 in Review
Weybosset Research & Management sold out of Pfizer (PFE) in Q2 2023, closing a stake of 8,397 shares — an estimated $343K sold.
Weybosset Research & Management first reported a position in PFE in Q1 2014 and held it in 35 quarters. The position peaked at $564K in Q3 2018. 3,041 funds tracked by Wall St. Rank hold PFE as of Q2 2023.
- Weybosset Research & Management reported no remaining Pfizer position as of Q2 2023 after selling out during the quarter.
- Weybosset Research & Management sold 8,397 Pfizer shares in Q2 2023, an estimated $343K.
- Weybosset Research & Management first reported a position in Pfizer in Q1 2014 and held it in 35 quarters.
- Weybosset Research & Management's Pfizer position peaked at $564K in Q3 2018.
- 3,041 funds tracked by Wall St. Rank held Pfizer as of Q2 2023.
Based on Weybosset Research & Management's 13F filing for Q2 2023, filed 12 Jul 2023.